Anti-Cancer Drug Derived From Himalayan Fungus Clears Early Clinical Trials

Anti-Cancer Drug Derived From Himalayan Fungus Clears Early Clinical Trials

An Oxford University study has shown that the new drug NUC-7738—a novel chemotherapy drug, derived from a fungus—has up to 40 times greater potency for killing cancer cells than its parent compound, with limited toxic side effects. The naturally-occurring nucleoside analogue known as Cordycepin (a.k.a 3’-deoxyadenosine) is found in the Himalayan fungus Cordyceps sinensis and […]

The post Anti-Cancer Drug Derived From Himalayan Fungus Clears Early Clinical Trials appeared first on Good News Network.


Source: Good News